Kay T W, d'Emden M C, Andrews J T, Martin F I
Department of Diabetes and Endocrinology, Royal Melbourne Hospital, Parkville, Victoria, Australia.
Am J Med. 1988 Jan;84(1):19-22. doi: 10.1016/0002-9343(88)90003-4.
Fourteen patients with large non-toxic multinodular goiters were treated with 20 to 100 mCi (740 to 3,700 MBq) of radioactive iodine (iodine-131). In seven, the goiter had recurred after a partial thyroidectomy and four of these had had two operations. Eight had symptoms of respiratory obstruction, two had dysphagia, and the others sought treatment for cosmetic reasons. After administration of iodine-131, there was a significant decrease in goiter size in 11 of the 14 patients, and all those with obstructive symptoms showed improvement. No significant local side effects occurred, but hypothyroidism and Graves' disease each occurred once during follow-up from one to 13 years. Radioactive iodine in doses of 20 to 100 mCi is an effective, safe therapeutic alternative in patients with large non-toxic multinodular goiter, particularly when there is recurrence following surgery or when there are contraindications to surgery.
14例患有巨大非毒性多结节性甲状腺肿的患者接受了20至100毫居里(740至3700兆贝可)的放射性碘(碘-131)治疗。其中7例患者在甲状腺部分切除术后甲状腺肿复发,且其中4例接受了两次手术。8例有呼吸阻塞症状,2例有吞咽困难,其他患者因美容原因寻求治疗。给予碘-131后,14例患者中有11例甲状腺肿大小显著减小,所有有阻塞症状的患者均有改善。未发生明显的局部副作用,但在1至13年的随访期间分别有1例发生甲状腺功能减退和格雷夫斯病。20至100毫居里剂量的放射性碘是巨大非毒性多结节性甲状腺肿患者有效的、安全的治疗选择,尤其是在手术后复发或存在手术禁忌证的情况下。